• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The cascade of care for household contacts of people with drug-resistant TB.

作者信息

Gomes I, Garg T, Churchyard G, Gupta A, Hesseling A C, Swindells S, Gurupira W, Martel B, Mbata L, Patil S, Riviere C, Tonquin M, Dowdy D, Sohn H

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Aurum Institute, Johannesburg, South Africa, School of Public Health, University of Witwatersrand, Johannesburg, South Africa, Department of Medicine, Vanderbilt University, Nashville, TN, USA.

出版信息

Int J Tuberc Lung Dis. 2023 Feb 1;27(2):154-156. doi: 10.5588/ijtld.22.0473.

DOI:10.5588/ijtld.22.0473
PMID:36853100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10115168/
Abstract
摘要

相似文献

1
The cascade of care for household contacts of people with drug-resistant TB.耐多药结核病患者家庭接触者的护理流程
Int J Tuberc Lung Dis. 2023 Feb 1;27(2):154-156. doi: 10.5588/ijtld.22.0473.
2
Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis.对于耐多药结核病患者的家庭接触者而言，等待已不再是一种选择。
Lancet Infect Dis. 2024 Sep;24(9):947-949. doi: 10.1016/S1473-3099(24)00233-0.
3
Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.在印度安得拉邦和特伦甘纳邦耐药结核病患者的家庭接触者中对利福平敏感和耐药结核病进行主动病例发现——一项系统筛查干预措施。
Indian J Tuberc. 2018 Jul;65(3):218-224. doi: 10.1016/j.ijtb.2018.02.004. Epub 2018 Feb 11.
4
Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.印度德里耐多药结核病患者家庭接触者中的结核病。
Int J Tuberc Lung Dis. 2011 Oct;15(10):1326-30. doi: 10.5588/ijtld.10.0564.
5
A study of multidrug resistant tuberculosis among symptomatic household contacts of MDR-TB patients.一项针对耐多药结核病患者有症状家庭接触者中的耐多药结核病的研究。
Indian J Tuberc. 2021 Jan;68(1):25-31. doi: 10.1016/j.ijtb.2020.09.030. Epub 2020 Oct 5.
6
An e-registry for household contacts exposed to multidrug resistant TB in Mongolia.蒙古国多耐药结核病家庭接触者电子登记册
BMC Med Inform Decis Mak. 2020 Aug 12;20(1):188. doi: 10.1186/s12911-020-01204-z.
7
Active contact tracing beyond the household in multidrug resistant tuberculosis in Vietnam: a cohort study.越南耐多药结核病中家庭以外的主动接触者追踪：一项队列研究。
BMC Public Health. 2019 Feb 28;19(1):241. doi: 10.1186/s12889-019-6573-z.
8
Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom.英国耐多药结核病患儿接触者的管理
Pediatr Infect Dis J. 2013 Aug;32(8):926-7. doi: 10.1097/INF.0b013e31829157e9.
9
High prevalence of multidrug-resistant TB among household contacts in a high burden setting.在高负担地区，家庭接触者中耐多药结核病的高流行率。
Int J Tuberc Lung Dis. 2023 Aug 1;27(8):646-648. doi: 10.5588/ijtld.23.0123.
10
Yield of systematic household contact investigation for tuberculosis in a high-burden metropolitan district of South Africa.南非高负担大都市地区系统家庭接触调查的结核病检出率。
BMC Public Health. 2019 Jul 3;19(1):867. doi: 10.1186/s12889-019-7194-2.

本文引用的文献

1
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.2019 年全球家庭接触管理对耐多药和利福平耐药结核病病例、死亡和卫生系统成本的影响：一项建模研究。
Lancet Glob Health. 2022 Jul;10(7):e1034-e1044. doi: 10.1016/S2214-109X(22)00113-9. Epub 2022 May 18.
2
Improving enrolment for TB preventive treatment.提高结核病预防性治疗的登记人数。
Int J Tuberc Lung Dis. 2022 Mar 1;26(3):291. doi: 10.5588/ijtld.21.0666.
3
Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.利奈唑胺群体药代动力学和浓度-QTc 分析在耐多药结核病儿科患者中的应用。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0160821. doi: 10.1128/AAC.01608-21. Epub 2021 Nov 29.
4
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.左氧氟沙星对比安慰剂治疗耐多药结核病患者接触者中潜伏性结核病（VQUIN MDR 试验）：一项随机对照试验方案。
BMJ Open. 2020 Jan 2;10(1):e033945. doi: 10.1136/bmjopen-2019-033945.
5
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.识别有进展为结核病高风险的利福平耐药和耐多药结核病病例家庭接触者的可行性
Clin Infect Dis. 2020 Jan 16;70(3):425-435. doi: 10.1093/cid/ciz235.
6
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.德拉马尼联合优化背景治疗方案治疗耐多药结核病的疗效和安全性：一项多中心、随机、双盲、安慰剂对照、平行分组 3 期临床试验。
Lancet Respir Med. 2019 Mar;7(3):249-259. doi: 10.1016/S2213-2600(18)30426-0. Epub 2019 Jan 7.
7
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).左氧氟沙星与安慰剂预防耐多药结核病儿童接触者结核病：一项III期整群随机对照试验（TB-CHAMP）的研究方案
Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0.
8
Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).耐多药结核病家庭接触者调查的资源利用（A5300/I2003）。
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1016-1022. doi: 10.5588/ijtld.18.0163.
9
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis.儿童耐多药结核病治疗中左氧氟沙星长期应用的临床与心脏安全性。
Clin Infect Dis. 2018 Nov 13;67(11):1777-1780. doi: 10.1093/cid/ciy416.
10
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.潜伏性结核感染诊断和治疗中的诊疗链：系统评价和荟萃分析。
Lancet Infect Dis. 2016 Nov;16(11):1269-1278. doi: 10.1016/S1473-3099(16)30216-X. Epub 2016 Aug 10.